References
- LinTGongLSunXHEffectiveness and safety of 0.5% ganciclovir in situ ophthalmic gel for herpes simplex keratitis, a multicenter, randomized, investigator-masked, parallel group study in Chinese patientsDrug Des Devel Ther20137361368
- ChenDZhangDXuLThe alterations of matrix metalloproteinase-9 in mouse brainstem during herpes simplex virus type 1-induced facial palsyJ Mol Neurosci201351370370923817985
- AlekseevODonovanKZaizkhan-CliffordJInhibition of ataxia telangiectasia mutated (ATM) kinase suppresses herpes simplex virus type 1 (HSV-1) keratitisInvest Ophthalmol Vis Sci201455270671524370835
- MesserHGJacobsDDhummakuptAInhibition of H3K27me3-specific histone demethylases JMJD3 and UTX blocks reactivation of herpes simplex virus 1 in trigeminal ganglion neuronsJ Virol20158963417342025552720
- SheppardJDWertheimerMLScoperSVModalities to decrease stromal herpes simplex keratitis reactivation ratesArch Ophthalmol2009127785285619597103
- ArefianEBamdadTSoleimanjahiHA kinetic study of gamma interferon production in herpes simplex virus-1 DNA prime-protein boost regimen comparing to DNA or subunit vaccinationMol Biol (Mosk)2009433388393
- HuKDouJYuFAn ocular mucosal administration of nanoparticles containing DNA vaccine Prsc-Gd-IL-21 confers protection against mucosal challenge with herpes simplex virus type 1 in miceVaccine20112971455146221185849
- TheopoldCPGheerardynRBleizifferOA novel replication-defective HSV-1 vector for regulatable gene delivery to woundsJ Am Coll Surg200419935758
- PalmerJABranstonRHLilleyCEDevelopment and optimization of herpes simplex virus vectors for multiple long-term gene delivery to the peripheral nervous systemJ Virol2000745604561810823868
- AnestiAMPeetersPJRoyauxIEfficient delivery of RNA interference to peripheral neurons in vivo using herpes simplex virusNucleic Acids Res20083614e8618583367
- XuKLiuXNZhangHBReplication-defective HSV-1 effectively targets targets trigeminal ganglion and inhibits viral pathopoiesis by mediating interferon gamma expression in SH-SY5Y cellsJ Mol Neurosci2014531788624347277
- XuKWangXShiQHuman prion protein mutants with deleted and inserted octarepeats undergo different pathways to trigger cell apoptosisJ Mol Neurosci201143322523420526696
- ChiangLCChiangWChangMYAntiviral activity of Plantago major extracts and related compounds in vitroAntiviral Res2002551536212076751
- WangXShiQXuKFamilial CJD associated PrP mutants within transmembrane region induced Ctm-PrP retention in ER and triggered apoptosis by ER stress in SH-SY5Y cellsPLoS One201161e1460221298055
- Shahidi BonjarMRShahidi BonjarLDesign of a new therapy for patients with chronic kidney disease: use of microarrays for selective hemoadsorption of uremic wastes and toxins to improve homeostasisDrug Des Devel Ther20159625629
- WhiteheadJLOharaPTTauscherANA procedure to deliver simplex virus to the murine trigeminal ganglionBrain Res Brain Res Protoc2003121606612928046
- MeunierALatremoliereAMauborgneAAttenuation of pain-related behavior in a rat model of trigeminal neuropathic pain by viral-driven enkephalin overproduction in trigeminal ganglion neuronsMol Ther201511460861615771963
- GoinsWFCohenJBGloriosoJCGene therapy for the treatment of chronic peripheral nervous system painNeurobiol Dis201248225527022668775
- FarooqAVShuklaDHerpes simplex epithelial and stromal keratitis: an epidemiologic updateSurv Ophthalmol201257544846222542912
- vanVelzenMvan LoenenFBMeestersRJLatent acyclovir-resistant herpes simplex virus type 1 in trigeminal ganglia of immunocompetent individualsJ Infect Dis2012205101539154322457282
- BieberTChosidowOBodsworthNEfficacy and safety of acyclovir mucoadhesive buccal tablet in immunocompetent patients with labial herpes: a double-blind placebo-controlled, self-initiated trialJ Drugs Dermatol201413779179825007361
- ColinJPrisantOCochenerBComparison of the efficacy and safety of valaciclovir and acyclovir for the treatment of herpes zoster ophthalmicusOphthalmology200010781507151110919899
- TurnerLDBeckingsalePAcyclovir-resistant herpetic keratitis in a solid-organ transplant recipient on systemic immunosuppressionClin Ophthalmol2013722923223386782
- SiaKCWangGYHoIAOptimal purification method for herpes-based viral vectors that confers minimal cytotoxicity for systemic route of vector administrationJ Virol Methods2007139216617417074404
- MoriuchiSKriskyDMMarconiPCHSV vector cytotoxicity is inversely correlated with effective TK/GCV suicide gene therapy of rat gliosarcomaGene Ther20007171483149011001368
- GoelNRongQZimmermanDALEAPS heteroconjugate vaccine containing a T cell epitope from HSV-1 glycoprotein D elicits Th1 responses and protectionVaccine20032127–304410442014505924
- QuenelleDCCollinsDJRiceTLEffect of an immune enhancer, GPI-100, on vaccination with live attenuated herpes simplex virus type 2 or glycoprotein D on genital HSV-2 infections of guinea pigsAntiviral Res200880222322418573279
- FeketeTPazmandiKSzaboAThe antiviral immune response in human conventional dendritic cells is controlled by the mammalian target of rapamycinJ Leukoc Biol201496457958925001862
- WangLCChengSOChangSPEnterovirus 71 proteins 2A and 3D antagonize the antiviral activity of gamma interferon via signaling attenuationJ Virol201589147028703725926657